BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 82 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,590,019 | -15.4% | 131,223 | +6.4% | 0.00% | 0.0% |
| Q2 2023 | $7,793,002 | +55.7% | 123,307 | +10.9% | 0.00% | +33.3% |
| Q1 2023 | $5,003,923 | +23.9% | 111,223 | +19.0% | 0.00% | 0.0% |
| Q4 2022 | $4,039,689 | -24.4% | 93,498 | +15.2% | 0.00% | -25.0% |
| Q3 2022 | $5,344,719 | +67.6% | 81,142 | +31.2% | 0.00% | +100.0% |
| Q2 2022 | $3,188,274 | -22.1% | 61,852 | -2.3% | 0.00% | -33.3% |
| Q1 2022 | $4,090,543 | +28.0% | 63,312 | +114.7% | 0.00% | +50.0% |
| Q4 2021 | $3,196,000 | +4.3% | 29,490 | -1.1% | 0.00% | -33.3% |
| Q3 2021 | $3,064,000 | +6.4% | 29,805 | -8.9% | 0.00% | +50.0% |
| Q2 2021 | $2,879,000 | -4.3% | 32,728 | +5.8% | 0.00% | -33.3% |
| Q1 2021 | $3,009,000 | -18.4% | 30,945 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $3,689,000 | +25.3% | 32,890 | +3.5% | 0.00% | 0.0% |
| Q3 2020 | $2,945,000 | +19.8% | 31,772 | -1.1% | 0.00% | +50.0% |
| Q2 2020 | $2,459,000 | +26.5% | 32,122 | -3.4% | 0.00% | 0.0% |
| Q1 2020 | $1,944,000 | -17.0% | 33,248 | +13.8% | 0.00% | 0.0% |
| Q4 2019 | $2,341,000 | +6.2% | 29,225 | -3.0% | 0.00% | 0.0% |
| Q3 2019 | $2,205,000 | -27.7% | 30,133 | -6.8% | 0.00% | -50.0% |
| Q2 2019 | $3,049,000 | +41.5% | 32,316 | +20.1% | 0.00% | +100.0% |
| Q1 2019 | $2,155,000 | +57.3% | 26,910 | +6.0% | 0.00% | 0.0% |
| Q4 2018 | $1,370,000 | -34.3% | 25,398 | -5.0% | 0.00% | 0.0% |
| Q3 2018 | $2,086,000 | +7.9% | 26,724 | -12.3% | 0.00% | 0.0% |
| Q2 2018 | $1,934,000 | -32.7% | 30,459 | -2.8% | 0.00% | -33.3% |
| Q1 2018 | $2,873,000 | +18.4% | 31,325 | -2.7% | 0.00% | 0.0% |
| Q4 2017 | $2,427,000 | +18.3% | 32,186 | +9.3% | 0.00% | +50.0% |
| Q3 2017 | $2,052,000 | +35.6% | 29,438 | -1.4% | 0.00% | 0.0% |
| Q2 2017 | $1,513,000 | +126.8% | 29,862 | +79.2% | 0.00% | +100.0% |
| Q1 2017 | $667,000 | +68.4% | 16,668 | +17.8% | 0.00% | 0.0% |
| Q4 2016 | $396,000 | -6.2% | 14,144 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $422,000 | +44.5% | 14,201 | -1.5% | 0.00% | – |
| Q2 2016 | $292,000 | +135.5% | 14,411 | +99.8% | 0.00% | – |
| Q1 2016 | $124,000 | -32.2% | 7,212 | +3.7% | 0.00% | – |
| Q4 2015 | $183,000 | +26.2% | 6,953 | +2.5% | 0.00% | – |
| Q3 2015 | $145,000 | -17.6% | 6,784 | +2.2% | 0.00% | – |
| Q2 2015 | $176,000 | – | 6,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |